158 related articles for article (PubMed ID: 38525660)
21. Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey.
Fine SW; Trpkov K; Amin MB; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; Costello T; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong MX; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Pavlovich CP; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Epstein JI
Urol Oncol; 2021 May; 39(5):295.e1-295.e8. PubMed ID: 32948433
[TBL] [Abstract][Full Text] [Related]
22. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
Tom MC; Nguyen JK; Lucianò R; Mian OY; Stephans KL; Ciezki JP; Smile TD; Wei W; McKenney JK; Magi-Galluzzi C; Tendulkar RD
J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
[TBL] [Abstract][Full Text] [Related]
23. The 2019 International Society of Urological Pathology Consensus Conference on Prostate Cancer Grading.
van Leenders GJLH; van der Kwast TH; Iczkowski KA
Eur Urol; 2021 Jun; 79(6):707-709. PubMed ID: 32847702
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of Prostate Biopsy for Detecting Cribriform Gleason Pattern 4 Carcinoma and Intraductal Carcinoma in Paired Radical Prostatectomy Specimens: Implications for Active Surveillance.
Ericson KJ; Wu SS; Lundy SD; Thomas LJ; Klein EA; McKenney JK
J Urol; 2020 Feb; 203(2):311-319. PubMed ID: 31483693
[TBL] [Abstract][Full Text] [Related]
25. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
26. Large-Gland Proliferations of the Prostate.
Iczkowski KA
Surg Pathol Clin; 2018 Dec; 11(4):687-712. PubMed ID: 30447836
[TBL] [Abstract][Full Text] [Related]
27. Current perspectives on the Gleason grading of prostate cancer.
Shah RB
Arch Pathol Lab Med; 2009 Nov; 133(11):1810-6. PubMed ID: 19886716
[TBL] [Abstract][Full Text] [Related]
28. Comparative influence of cribriform growth and percent Gleason 4 in prostatic biopsies with Gleason 3+4 cancer.
Czaja RC; Tarima S; Wu R; Palagnmonthip W; Iczkowski KA
Ann Diagn Pathol; 2021 Jun; 52():151725. PubMed ID: 33610958
[TBL] [Abstract][Full Text] [Related]
29. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists.
Gandhi JS; Smith SC; Paner GP; McKenney JK; Sekhri R; Osunkoya AO; Baras AS; DeMarzo AM; Cheville JC; Jimenez RE; Trpkov K; Colecchia M; Ro JY; Montironi R; Menon S; Hes O; Williamson SR; Hirsch MS; Netto GJ; Fine SW; Sirohi D; Kaushal S; Sangoi A; Robinson BD; Kweldam CF; Humphrey PA; Hansel DE; Schultz L; Magi-Galluzzi C; Przybycin CG; Shah RB; Mehra R; Kunju LP; Aron M; Kryvenko ON; Kench JG; Kuroda N; Tavora F; van der Kwast T; Grignon DJ; Epstein JI; Reuter VE; Amin MB
Am J Surg Pathol; 2020 May; 44(5):673-680. PubMed ID: 31876580
[TBL] [Abstract][Full Text] [Related]
30. Gleason grading and prognostic factors in carcinoma of the prostate.
Humphrey PA
Mod Pathol; 2004 Mar; 17(3):292-306. PubMed ID: 14976540
[TBL] [Abstract][Full Text] [Related]
31. PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma).
Shah RB; Shore KT; Yoon J; Mendrinos S; McKenney JK; Tian W
Prostate; 2019 Aug; 79(11):1267-1273. PubMed ID: 31111513
[TBL] [Abstract][Full Text] [Related]
32. Grading of prostatic adenocarcinoma: current state and prognostic implications.
Gordetsky J; Epstein J
Diagn Pathol; 2016 Mar; 11():25. PubMed ID: 26956509
[TBL] [Abstract][Full Text] [Related]
33. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
[TBL] [Abstract][Full Text] [Related]
34. Prostate Cancer Grading: A Decade After the 2005 Modified Gleason Grading System.
Kryvenko ON; Epstein JI
Arch Pathol Lab Med; 2016 Oct; 140(10):1140-52. PubMed ID: 26756649
[TBL] [Abstract][Full Text] [Related]
35. Intraductal Carcinoma of the Prostate: Morphologic Features, Differential Diagnoses, Significance, and Reporting Practices.
Magers M; Kunju LP; Wu A
Arch Pathol Lab Med; 2015 Oct; 139(10):1234-41. PubMed ID: 26414467
[TBL] [Abstract][Full Text] [Related]
36. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists.
Iczkowski KA; Egevad L; Ma J; Harding-Jackson N; Algaba F; Billis A; Camparo P; Cheng L; Clouston D; Comperat EM; Datta MW; Evans AG; Griffiths DF; Guo CC; Hailemariam S; Huang W; Humphrey PA; Jiang Z; Kahane H; Kristiansen G; La Rosa FG; Lopez-Beltran A; MacLennan GT; Magi-Galluzzi C; Merrimen J; Montironi R; Osunkoya AO; Picken MM; Rao N; Shah RB; Shanks JH; Shen SS; Tawfik OW; True LD; Van der Kwast T; Varma M; Wheeler TM; Zynger DL; Sahr N; Bostwick DG
Ann Diagn Pathol; 2014 Dec; 18(6):333-42. PubMed ID: 25263387
[TBL] [Abstract][Full Text] [Related]
37. Correlation between cribriform/intraductal prostatic adenocarcinoma and percent Gleason pattern 4 to a 22-gene genomic classifier.
Taylor AS; Morgan TM; Wallington DG; Chinnaiyan AM; Spratt DE; Mehra R
Prostate; 2020 Feb; 80(2):146-152. PubMed ID: 31737920
[TBL] [Abstract][Full Text] [Related]
38. Intraductal carcinoma of prostate reporting practice: a survey of expert European uropathologists.
Varma M; Egevad L; Algaba F; Berney D; Bubendorf L; Camparo P; Comperat E; Erbersdobler A; Griffiths D; Grobholz R; Haitel A; Hulsbergen-van de Kaa C; Langner C; Loftus B; Lopez-Beltran A; Mayer N; Nesi G; Oliveira P; Oxley J; Rioux-Leclercq N; Seitz G; Shanks J; Kristiansen G
J Clin Pathol; 2016 Oct; 69(10):852-7. PubMed ID: 26926101
[TBL] [Abstract][Full Text] [Related]
39. Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists.
Kweldam CF; Nieboer D; Algaba F; Amin MB; Berney DM; Billis A; Bostwick DG; Bubendorf L; Cheng L; Compérat E; Delahunt B; Egevad L; Evans AJ; Hansel DE; Humphrey PA; Kristiansen G; van der Kwast TH; Magi-Galluzzi C; Montironi R; Netto GJ; Samaratunga H; Srigley JR; Tan PH; Varma M; Zhou M; van Leenders GJ
Histopathology; 2016 Sep; 69(3):441-9. PubMed ID: 27028587
[TBL] [Abstract][Full Text] [Related]
40. An update of the Gleason grading system.
Epstein JI
J Urol; 2010 Feb; 183(2):433-40. PubMed ID: 20006878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
